Maryland Bioservices, Inc.

Maryland Bioservices uses the cotton rat model for efficacy testing of anti-virals and vaccines for human respiratory viral and bacterial infections.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Gaithersburg, MD, USA
  • Currency USD
  • Founded 2013

Company Summary

Maryland Bioservices, Inc (MBI) provides in vivo/in vitro testing services of candidate vaccines and antivirals for human respiratory viruses, including (but not limited to) influenza and respiratory syncytial virus. MBI utilizes small animal models such as the mouse or cotton rat. Our internal research programs continue to further our service capabilities through the development of proprietary monoclonal antibodies to cotton rat molecules.

Team

  • Richard Schuman
    Director

    Richard F. Schuman, Ph.D. is CEO of Maryland Bioservices. Dr. Schuman is currently the CEO of Antibody and Immunoassay Consultants, LLC and was Principal Scientist and Director of Immunoassay Services at BioReliance Corporation and the Associate Director of Immunochemistry for Covance, Inc. Dr. Schuman's has developed over 50 monoclonal antibodies during his career and worked extensively with in vivo and in vitro models of infectious diseases.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free